DK0745063T3 - Substituerede biphenyl-derivater med phosphodiesterase-inhiberende virkning - Google Patents

Substituerede biphenyl-derivater med phosphodiesterase-inhiberende virkning

Info

Publication number: DK0745063T3
Authority: DK; Denmark
Prior art keywords: co2r3; noh; cycloalkyl; aryl; alkyl
Prior art date: 1994-02-17

Application number

DK95908671T

Other languages

Danish (da)

English (en)

Inventor

Thomas Joseph Caggiano

Joseph Prol Jr

Original Assignee

American Home Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-02-17

Filing date

1995-01-25

Publication date

1999-10-11

1995-01-25 Application filed by American Home Prod filed Critical American Home Prod

1999-10-11 Application granted granted Critical

1999-10-11 Publication of DK0745063T3 publication Critical patent/DK0745063T3/da

Links

102000004861 Phosphoric Diester Hydrolases Human genes 0.000 title 1
108090001050 Phosphoric Diester Hydrolases Proteins 0.000 title 1
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 title 1
230000002401 inhibitory effect Effects 0.000 title 1
125000003118 aryl group Chemical group 0.000 abstract 3
125000000753 cycloalkyl group Chemical group 0.000 abstract 3
125000000217 alkyl group Chemical group 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
101100134925 Gallus gallus COR6 gene Proteins 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
208000026935 allergic disease Diseases 0.000 abstract 1
230000000172 allergic effect Effects 0.000 abstract 1
-1 aryalkyl Chemical group 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
208000006673 asthma Diseases 0.000 abstract 1
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
125000003709 fluoroalkyl group Chemical group 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 abstract 1
125000000716 hydrazinylidene group Chemical group [*]=NN([H])[H] 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
208000027866 inflammatory disease Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/44—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/235—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring and to a carbon atom of a ring other than a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/235—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring and to a carbon atom of a ring other than a six-membered aromatic ring
- C07C43/247—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring and to a carbon atom of a ring other than a six-membered aromatic ring containing halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
- C07C65/26—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic containing rings other than six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Liquid Crystal Substances (AREA)
Electroluminescent Light Sources (AREA)

DK95908671T 1994-02-17 1995-01-25 Substituerede biphenyl-derivater med phosphodiesterase-inhiberende virkning DK0745063T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US19803194A	1994-02-17	1994-02-17
PCT/US1995/000996 WO1995022520A1 (en)	1994-02-17	1995-01-25	Substituted biphenyl derivatives as phosphodiesterase inhibitors

Publications (1)

Publication Number	Publication Date
DK0745063T3 true DK0745063T3 (da)	1999-10-11

Family

ID=22731725

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95908671T DK0745063T3 (da)	1994-02-17	1995-01-25	Substituerede biphenyl-derivater med phosphodiesterase-inhiberende virkning

Country Status (19)

Country	Link
US (1)	US5650444A (es)
EP (1)	EP0745063B1 (es)
JP (1)	JPH09510191A (es)
KR (1)	KR970701170A (es)
AT (1)	ATE178046T1 (es)
AU (1)	AU692839B2 (es)
CA (1)	CA2182792A1 (es)
DE (1)	DE69508568T2 (es)
DK (1)	DK0745063T3 (es)
ES (1)	ES2130597T3 (es)
FI (1)	FI963228A7 (es)
GR (1)	GR3030490T3 (es)
HU (1)	HUT74611A (es)
IL (1)	IL112538A (es)
MX (1)	MX9603414A (es)
NZ (1)	NZ279689A (es)
SG (1)	SG47624A1 (es)
TW (1)	TW394757B (es)
WO (1)	WO1995022520A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4373497B2 (ja)	1996-06-19	2009-11-25	ローン−プーラン・ロレ・リミテツド	置換されたアザビシクロ化合物、ならびにｔｎｆおよびサイクリックａｍｐホスホジエステラーゼ産生の阻害剤としてのそれらの使用
EA002113B1 (ru)	1996-09-04	2001-12-24	Пфайзер Инк.	Производные индазола и их использование в качестве ингибиторов фосфодиэстеразы (фдэ) типа iv и продуцирования фактора некроза опухоли (фно)
US5981549A (en) *	1997-02-14	1999-11-09	Synapse Pharmaceutical International	Method for controlling or alleviating the symptoms of respiratory disease and allergies
EP0934933A1 (en) *	1998-02-06	1999-08-11	Byk Gulden Lomberg Chemische Fabrik GmbH	Phthalazinones
CA2715683A1 (en)	1999-08-21	2001-03-01	Nycomed Gmbh	Synergistic combination
JP2003508391A (ja)	1999-08-31	2003-03-04	マキシア・ファーマシューティカルズ・インコーポレイテッド	ベンジリデン−チアゾリジンジオン類およびアナログ類ならびに糖尿病の治療におけるその使用
US6376524B1 (en) *	2000-06-21	2002-04-23	Sunesis Pharmaceuticals, Inc.	Triphenyl compounds as interleukin-4 antagonists
AU2002252227A1 (en)	2001-03-07	2002-09-24	Maxia Pharmaceuticals, Inc.	Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
JP2004523571A (ja) *	2001-03-08	2004-08-05	マキシア・ファーマシューティカルズ・インコーポレイテッド	Ｒｘｒ活性化分子
CA2340824A1 (en) *	2001-03-14	2002-09-14	Ibm Canada Limited-Ibm Canada Limitee	Method and system for application behavior analysis
WO2003016267A1 (en) *	2001-08-17	2003-02-27	Incyte San Diego Incorporated	Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
JP2005513026A (ja) *	2001-11-15	2005-05-12	インサイトサンディエゴインコーポレイテッド	高コレステロール血症、異脂肪血症および他の代謝障害；癌、および他の疾患を治療するｎ−置換複素環
US7196108B2 (en) *	2002-03-08	2007-03-27	Incyte San Diego Inc.	Bicyclic heterocycles for the treatment of diabetes and other diseases
US7102000B2 (en) *	2002-03-08	2006-09-05	Incyte San Diego Inc.	Heterocyclic amide derivatives for the treatment of diabetes and other diseases
US6706895B1 (en) *	2002-11-14	2004-03-16	Uniroyal Chemical Company, Inc.	4-methoxybiphenyl hydrazone derivatives
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
US20050014767A1 (en) *	2003-01-29	2005-01-20	Magnus Pfahl	Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
US7153824B2 (en)	2003-04-01	2006-12-26	Applied Research Systems Ars Holding N.V.	Inhibitors of phosphodiesterases in infertility
US20050038098A1 (en) *	2003-04-18	2005-02-17	Catherine Tachdjian	Substituted dihydronaphthalene and isochroman compounds for the treatment of metabolic disorders, cancer and other diseases
US7279600B2 (en) *	2003-05-02	2007-10-09	Wyeth	Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents
WO2007009083A2 (en) *	2005-07-12	2007-01-18	Acadia Pharmaceuticals Inc.	Compounds with activity at retinoic acid receptors
PE20070182A1 (es)	2005-07-29	2007-03-06	Wyeth Corp	Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es)	2007-06-04	2018-03-21	Synergy Pharmaceuticals Inc	Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
ES2522968T3 (es)	2008-06-04	2014-11-19	Synergy Pharmaceuticals Inc.	Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en)	2008-07-16	2015-02-19	Bausch Health Ireland Limited	Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9051290B2 (en)	2010-04-28	2015-06-09	Leo Pharma A/S	Biaryl phosphodiesterase inhibitors
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
DK2681236T3 (en)	2011-03-01	2018-04-16	Synergy Pharmaceuticals Inc	PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
US9890200B2 (en) *	2011-04-12	2018-02-13	Moerae Matrix, Inc.	Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
WO2014131024A2 (en)	2013-02-25	2014-08-28	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
AU2014235215A1 (en)	2013-03-15	2015-10-01	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
AU2014235209B2 (en)	2013-03-15	2018-06-14	Bausch Health Ireland Limited	Guanylate cyclase receptor agonists combined with other drugs
BR112015030326A2 (pt)	2013-06-05	2017-08-29	Synergy Pharmaceuticals Inc	Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
AU2014305843B2 (en)	2013-08-09	2019-08-29	Ardelyx, Inc.	Compounds and methods for inhibiting phosphate transport
EP4706758A3 (en)	2019-05-21	2026-05-06	Ardelyx, Inc.	Methods for inhibiting phosphate transport

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2759964A (en) *	1953-07-09	1956-08-21	Dow Chemical Co	Dialkylaminoalkyl esters of phenyl substituted dihydroxybenzoic acids
US2716663A (en) *	1953-07-09	1955-08-30	Dow Chemical Co	Hydrazides of phenyl substituted dihydroxybenzoic acids
US2921939A (en) *	1955-11-28	1960-01-19	Metal & Thermit Corp	Process for preparing alpha-substituted acetic acids
US3043746A (en) *	1959-11-02	1962-07-10	Vismara Francesco Spa	2-(4-biphenylyl)-delta-hexenoic acid and derivatives as anticholesterinemic agents
US3120551A (en) *	1961-03-20	1964-02-04	Warner Lambert Pharmaceutical	5-(4-biphenylyl)-3-methylvaleric acid and functional derivatives thereof
US3624142A (en) *	1964-09-10	1971-11-30	Merck & Co Inc	Substituted biphenyl acetic acid derivatives
US3457300A (en) *	1965-06-11	1969-07-22	Merck & Co Inc	Acetic acid type compounds
US3681445A (en) *	1968-01-19	1972-08-01	Merck & Co Inc	Substituted phenyl benzoic acid compounds
US3671580A (en) *	1969-12-22	1972-06-20	Merck & Co Inc	Substituted biphenyl acetic acids and ester derivatives thereof
GB1433130A (en) *	1972-11-09	1976-04-22	Secr Defence	Substituted biphenyl and polyphenyl compounds and liquid crystal materials and devices containing them
GB1459084A (en) *	1973-05-24	1976-12-22	Boots Co Ltd	Preparation of arylalkanoic acid
JPS5387340A (en) *	1977-01-10	1978-08-01	Seiko Epson Corp	Method of synthesis
US4916145A (en) *	1987-07-10	1990-04-10	Hoffmann-La Roche Inc.	Substituted n-[(pyridyl)alkyl]aryl-carboxamide
DE3903988A1 (de) *	1989-02-10	1990-08-30	Basf Ag	Oxidierte diphenylheteroalkane, ihre herstellung und verwendung
DE3903989A1 (de) *	1989-02-10	1990-09-20	Basf Ag	Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
GB9007762D0 (en) *	1990-04-05	1990-06-06	Beecham Group Plc	Novel compounds
CA2044533A1 (en) *	1990-06-29	1991-12-30	Philippe Guerry	Substituted aminoalkylbiphenyl derivatives
EP0553174B1 (de) *	1990-10-16	1998-07-08	Byk Gulden Lomberg Chemische Fabrik Gmbh	Arylpyridazinone
JP3333510B2 (ja) *	1991-10-02	2002-10-15	スミスクライン・ビーチャム・コーポレイション	抗アレルギー、抗炎症および腫瘍壊死因子抑制活性を有するシクロペンタンおよびシクロペンテン誘導体
GB9222253D0 (en) *	1992-10-23	1992-12-09	Celltech Ltd	Chemical compounds
NZ257955A (en) *	1992-12-02	1996-05-28	Pfizer	Catechol diethers pharmaceutical compositions

1995
- 1995-01-25 EP EP95908671A patent/EP0745063B1/en not_active Expired - Lifetime
- 1995-01-25 HU HU9602267A patent/HUT74611A/hu unknown
- 1995-01-25 DK DK95908671T patent/DK0745063T3/da active
- 1995-01-25 JP JP7521806A patent/JPH09510191A/ja active Pending
- 1995-01-25 CA CA002182792A patent/CA2182792A1/en not_active Abandoned
- 1995-01-25 ES ES95908671T patent/ES2130597T3/es not_active Expired - Lifetime
- 1995-01-25 DE DE69508568T patent/DE69508568T2/de not_active Expired - Fee Related
- 1995-01-25 AT AT95908671T patent/ATE178046T1/de not_active IP Right Cessation
- 1995-01-25 WO PCT/US1995/000996 patent/WO1995022520A1/en not_active Ceased
- 1995-01-25 NZ NZ279689A patent/NZ279689A/xx unknown
- 1995-01-25 AU AU16905/95A patent/AU692839B2/en not_active Ceased
- 1995-01-25 MX MX9603414A patent/MX9603414A/es unknown
- 1995-02-03 IL IL11253895A patent/IL112538A/xx not_active IP Right Cessation
- 1995-02-07 TW TW084100953A patent/TW394757B/zh active
- 1995-05-25 US US08/452,593 patent/US5650444A/en not_active Expired - Lifetime
- 1995-06-25 SG SG1996003239A patent/SG47624A1/en unknown
1996
- 1996-08-16 KR KR1019960704462A patent/KR970701170A/ko not_active Ceased
- 1996-08-16 FI FI963228A patent/FI963228A7/fi unknown
1999
- 1999-06-10 GR GR990401565T patent/GR3030490T3/el unknown

Also Published As

Publication number	Publication date
JPH09510191A (ja)	1997-10-14
WO1995022520A1 (en)	1995-08-24
DE69508568T2 (de)	1999-10-21
IL112538A (en)	1999-09-22
AU692839B2 (en)	1998-06-18
NZ279689A (en)	1997-08-22
KR970701170A (ko)	1997-03-17
DE69508568D1 (de)	1999-04-29
SG47624A1 (en)	1998-04-17
ATE178046T1 (de)	1999-04-15
HUT74611A (en)	1997-01-28
EP0745063B1 (en)	1999-03-24
AU1690595A (en)	1995-09-04
MX9603414A (es)	1997-03-29
TW394757B (en)	2000-06-21
HU9602267D0 (en)	1996-10-28
US5650444A (en)	1997-07-22
CA2182792A1 (en)	1995-08-24
IL112538A0 (en)	1995-05-26
EP0745063A1 (en)	1996-12-04
FI963228A0 (fi)	1996-08-16
ES2130597T3 (es)	1999-07-01
FI963228A7 (fi)	1996-08-16
GR3030490T3 (en)	1999-10-29

Publication	Publication Date	Title
DK0745063T3 (da)	1999-10-11	Substituerede biphenyl-derivater med phosphodiesterase-inhiberende virkning
NZ233735A (en)	1992-10-28	Heterocyclic substituted aminophenol derivatives
TW349097B (en)	1999-01-01	Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
TR200000595T2 (tr)	2000-12-21	2,3-Diaril-pirazolo[1,5-B]piridazinler türevleri, bunların hazırlanması ve bunların siklooksijenaz 2 (COX-2) inhibitörleri olarak kullanılması.
YU40997A (sh)	2000-10-30	Novi oksadiazoli, postupci za njihovo pripremanje
EA200100678A1 (ru)	2001-12-24	N-уреидоалкил-пиперидины в качестве модуляторов активности рецепторов хемокинов
DK0804252T3 (da)	2003-10-06	Monoamin-, diamid-, thiol-holdige metalchelateringsmidler
MX9708621A (es)	1998-02-28	AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS.
HUP9601285A2 (hu)	1998-09-28	Szubsztituált N-(indol-2-karbonil)-béta-alanin-amidok és származékaik, valamint e vegyületeket tartalmazó gyógyászati készítmények
ES2189968T3 (es)	2003-07-16	Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS.
EA199900620A1 (ru)	2000-04-24	Фталазиноны
BR9106657A (pt)	1993-06-08	Composicao de revestimento interno de pneu,e,pneu vulcanizado compreendendo um revestimento interno
NO305287B1 (no)	1999-05-03	AMPA antagonister
ATE180781T1 (de)	1999-06-15	Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
TR200200125T2 (tr)	2002-09-23	Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
HUP9700955A2 (hu)	1998-03-02	Szubsztituált 2-naftoil-guanidin-származékok, előállításuk, valamint az e vegyületeket tartalmazó gyógyszerkészítmények
FR2631625B1 (fr)	1992-10-16	Derives de phenyl-6 piperazinylalkyl-3 1h,3h-pyrimidinedione-2,4, leur preparation et leur application en therapeutique
ES8407066A1 (es)	1984-08-16	Derivados de 6 -metilprednisolona.
TR200001941T1 (tr)	2001-01-22	TNF ve PDE-IV önleyici aktiviteye sahip heterosiklik bileşiklerin N-oksitleri.
ATE197458T1 (de)	2000-11-11	Verbesserte antiandrogene
BG103271A (en)	2000-05-31	Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
DE69403804D1 (de)	1997-07-17	Antiparasitiches mittel
BG98238A (bg)	1995-02-28	Заместени бензотиазолови производни,получаванетоим и приложението им като хербициди
DE68926418D1 (de)	1996-06-13	S'-adenosyl-methionin-decarboxylase-Inhibitoren
AP2002002595A0 (en)	2002-09-30	Heterocyclic amide derivatives.